31 results
424B5
EVOK
Evoke Pharma Inc
14 Jan 21
Prospectus supplement for primary offering
5:19pm
the election of directors, and do not have cumulative voting rights. Accordingly, the holders of a majority of the outstanding shares of common stock … and conversion period;
voting rights, if any, of the preferred stock;
a discussion of any material or special U.S. federal income tax considerations
424B5
EVOK
Evoke Pharma Inc
13 Jan 21
Prospectus supplement for primary offering
4:34pm
the election of directors, and do not have cumulative voting rights. Accordingly, the holders of a majority of the outstanding shares of common stock … and conversion period;
voting rights, if any, of the preferred stock;
a discussion of any material or special U.S. federal income tax considerations
424B5
EVOK
Evoke Pharma Inc
22 Jul 16
Prospectus supplement for primary offering
12:00am
not have cumulative voting rights. Accordingly, the holders of a majority of the outstanding shares of common stock entitled to vote in any election … ;
voting rights, if any, of the preferred stock;
a discussion of any material or special U.S. federal income tax considerations applicable
424B5
EVOK
Evoke Pharma Inc
20 Jul 16
Prospectus supplement for primary offering
12:00am
to a vote of stockholders, including the election of directors, and do not have cumulative voting rights. Accordingly, the holders of a majority … , including the conversion price or manner of calculation and conversion period;
voting rights, if any, of the preferred stock;
a discussion of any material
424B4
2jflj2d6my
9 Feb 24
Prospectus supplement with pricing info
5:14pm
8-K
EX-4.1
l6h0ardbovf 2egwr
20 Jul 16
Evoke Pharma Announces $4.5 Million At-The-Market Offering
12:00am
8-K
EX-4.1
q8jn6j1og86o2
14 Feb 24
Unregistered Sales of Equity Securities
9:00am
PRE 14A
cdn41
12 Mar 21
Preliminary proxy
8:30am